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flect Job' s mutations. Constructs were cotransfected into a STAT3
deficient cell line (Cos1) as well as a cell line with endogenous
STAT3 (HeLa) along with a STAT3-responsive luciferase reporter
vector. Peripheral blood mononuclear cells (PBMCs) from Job' s pa-
tients were used to measure STAT3 activation in nuclear extracts
by STAT3 binding to DNA in an ELISA assay. NFκB nuclear translo-
cation was detected with confocal microscopy using antibodies to
p65 and p50. p38 MAP kinase activity was measured by ELISA. De-
phosphorylation of STAT3 was examined by immunoblot.
Results: Mutations within both the DNA binding and SH2 domains
result in loss-of-function but are dominant negative. Mutant con-
structs in Cos-1 cells did not transactivate the STAT3 reporter and
transfection in HeLa cells resulted in a decrease of luciferase ac-
tivity by 80-84% as compared with wild type after stimulation with
oncostatin M. Cotransfection of wild type and mutant constructs
together in Cos-1 cells resulted in 24-63% loss of activity. IL10 plus
lipopolysaccharide (LPS) stimulation of PBMCs from Job' s patients
resulted in a 14-fold decrease in STAT3 activity as compared to
normals as measured by ELISA. Following LPS stimulation, p38 MAP
kinase phosphorylation between normal and Job' s cells were com-
parable, but NFκB activity was higher in Job' s cells. Dephosphory-
lation of STAT3 was normal in PBMCs from Job' s patients following
treatment with staurosporine.
Conclusions: Job' s STAT3 mutations act in a dominant negative
manner. Both DNA binding and SH2 mutations decrease activation
of STAT3 in response to several stimuli impairing downstream sig-
naling. These methods to evaluate the function of STAT3 mutants
will help dissect mechanisms of STAT3 control of susceptibility to
infection and control of inflammation.
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The First Report of Somatic Mutation Reversion X-Linked
Chronic Granulomatous Disease
Gulbu Uzel, Douglas Kuhns, Gilda Linton, Paul Quie,
Steven Holland. NIH, NIAID, Laboratory of Clinical Infectious
Diseases, Bethesda, MD, USA
Introduction: X-linked chronic granulomatous disease (CGD) is
caused by mutations in the CYBB gene, which impair gp91phox
function and therefore lead to deficient superoxide generation
by the phagocyte NADPH oxidase system. This leads to defective
killing of certain bacteria and fungi and results in severe infections
and granuloma formation.
Case: A 20-year-old man with X-linked CGD had a long history
of classic CGD and severe inflammatory bowel disease requiring
colonic diversion. He had two distinct populations of neutrophils
by neutrophil oxidative burst testing of peripheral blood. In
two independent measurements of neutrophil oxidative burst by
dihydrorhodamine (DHR) assay, 97% of peripheral blood neutrophils
failed to oxidize dihydrorhodamine (DHR-), while 3% had a normal
oxidative capacity (DHR+). Sorted DHR+ and DHR- cells were stud-
ied by microsatellite analyses, which proved patient origin of both
the DHR+ and DHR- cells. The DHR- cells and buccal mucosal ep-
ithelial cells and unsorted peripheral blood mononuclear cells had
the mutation 676C>T, which causes a premature stop (R226X) in
CYBB. In contrast, the DHR+ cells had the wild-type sequence, 676C
leading to a normal protein. Therefore, since he had the majority
of his peripheral blood and his buccal cells mutant, and only a small
percentage reverted to normal, we believe that he has reverted
the mutation in a small population of his neutrophil precursors. Ex-
ploration of other cell lines (lymphoid, monocyte, etc) is underway.
Discussion: Somatic mosaicism due to site-specific reversions of
inherited mutations to wild type has been described in other im-
munodeficiencies and has been linked to milder disease in some
cases. This is the first report of a reversion mutation in X-linked
CGD, and the only report of a reversion mutation affecting neu-
trophils in a primary phagocyte defect. Reversion mutations can
occur in neutrophils, just as they do in lymphocytes and may be
more common than previously thought.
12
Filamentous Fungal Pneumonias in Hyper IgE Syndrome
Donald Vinh, Alexandra F. Freeman, Amy Hsu, Steven Holland.
National Institute of Allergy & Infectious Diseases Laboratory of
Clinical Infectious Diseases, Bethesda, USA
Background: Autosomal dominant hyper-IgE syndrome (AD-HIES,
Job' s syndrome) is a primary immunodeficiency characterized by
recurrent staphylococcal abscesses, pneumonia, eczema, and el-
evated serum IgE. Connective tissue defects are also frequent.
AD-HIES results from heterozygous hypomorphic mutations in the
STAT3 gene, primarily affecting either the SH2 or DNA-binding do-
mains. Filamentous fungal pneumonias (FFP), particularly with As-
pergillus spp., have been reported in patients with clinically sus-
pected AD-HIES. However, these reports pre-dated the ability to
genotypically confirm the patients' diagnoses and have been lim-
ited in sample size, precluding comprehensive understanding of
this infection in AD-HIES. We sought to determine the prevalence
of FFP in a large cohort of patients with confirmed AD-HIES.
Methods: Retrospective chart review of all AD-HIES patients fol-
lowed at the NIH, for which the diagnosis was confirmed by genetic
sequencing.
Results: 56 AD-HIES patients with STAT3 mutations were identi-
fied: 22 (39.3%) had no radiological evidence of lung cysts (includes
cavities, pneumatoceles), while 34 (60.7%) did. Among those with-
out cysts, none (0%) developed FFP. Among those with lung cysts,
13 (38.2%) developed FFP. Aspergillus/Neosartorya spp. were most
common (11 total, 84.6%); infection with S. apiospermum (n=1)
and H. capsulatum (n=1) also occurred. Multiple episodes of FFP
frequently occurred in affected patients and did not occur exclu-
sively in pre-existing cysts. Patients were stratified based on their
mutation (SH2, n=28; DNA, n=28). Lung cysts were equally fre-
quent in each group (n=17 for both). The number of patients in
each group with lung cysts developing FFP was similar (SH2: 7/17
(41.2%); DNA: 6/17 (35.3%)) as was the median age at onset of
1st FFP (SH2: 30.5 yrs; DNA: 35.5 yrs). Treatment modalities var-
ied and included antifungal agents (systemic, occasionally adjunc-
tive intra-cavitary) with or without surgical resection. Mortality
occurred more frequently in the DNA group (3/6; 50%) than in the
SH2 group (0/7; 0%).
Conclusions: Patients with AD-HIES with lung cysts are at signifi-
cantly increased risk for FFP, typically in their third decade of life.
FFP do not necessarily occur only in pre-existing cysts/cavities,
suggesting that cysts/cavities may be a marker for susceptibility
rather than a cause of the infection. Aspergillus spp. are the pri-
mary pathogens. The mortality rate is significant and possibly re-
lated to genotype.
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Herniated Nuclear Morphology and Cytoskeletal Anomalies
in Neutrophils from Sisters with Recurrent Infections
Douglas Kuhns1, Donald Vinh2, Gulbu Uzel2, John Gallin3,
Steven Holland2. 1Clinical Services Program, SAIC-Frederick, Inc.,
NCI-Frederick, USA; 2Laboratory of Clinical Infectious Diseases,
NIAID, NIH, Bethesda, USA; 3Laboratory of Host Defenses, NIAID,
NIH, Bethesda, USA
Background: Two Qatari sisters (5 and 12 yrs.) with a family his-
tory of consanguinity (parents are first cousins) and suspected neu-
trophil dysfunction had frequent severe skin and mucosal ulcera-
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tions, recurrent upper and lower respiratory tract infections, and
neutropenia. The younger sister had repeated oral infections that
ultimately resulted in development of oral strictures. A twin sister
of the younger child who had a similar presentation died at age 3
years from a septic event.
Objective: To characterize the functional responses of patient neu-
trophils as a way to identify the underlying immunodeficiency.
Methods and Results: Neutrophils from both sisters exhibited nor-
mal O2- production to phorbol myristate, fMLF, and cytochalasin
B + zymosan. Although degranulation and staphylocidal activity
were not dramatically altered, a profound chemotactic defect
in vitro was detected. Microscopic examination of purified neu-
trophils from both sisters showed abnormal nuclear morphology in
40-50% of the cells with herniation of nuclear lobes into plasma
membrane-enclosed surface blebs. No abnormal morphology was
observed in the neutrophils on routine peripheral blood smears.
Electron microscopic examination of isolated cells confirmed ab-
normal morphology in both neutrophils and eosinophils. Moreover,
herniation of nuclear lobes coincided with retraction of the gran-
ules into the central region of the cells, resulting in an agranu-
lar region in the periphery of the cell. Confocal microscopy, using
Alexa Fluor 546-phalloidin to identify filamentous actin and DAPI
to localize nuclei, showed that cells with herniated nuclear lobes
exhibited increased levels of filamentous actin compared to either
patient cells with normal nuclear lobes or to normal neutrophils.
Conclusion: Abnormal nuclear morphology, profound chemotactic
defect, and cytoskeletal anomaly in these two sisters with recur-
rent infections represents a novel defect of neutrophils that is
likely autosomal recessive.
Funded in part by NCI Contract N01-CO-12400.
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A Novel Autosomal-dominant Late-onset Immunodeficiency
with Susceptibility to Mycobacteria, Fungi, Papillomavirus
and Myeloid Malignancies
Donald Vinh, Smita Patel, Gulbu Uzel, Victoria Anderson,
Alexandra Freeman, Kenneth Olivier, Houda Elloumi, Li Ding,
Douglas Kuhns, Danielle Fink, Deborah Long-Priel, Frank DeLeo,
Elizabeth Sampaio, Michelle Paulson, Amy Hsu, Adrian Zelazny,
Jeremy Root, David Frucht, Steven Holland. National Institutes of
Health (NIH) National Institute of Allergy & Infectious Diseases
Laboratory of Clinical Infectious Diseases Bethesda, USA
Background: Primary immunodeficiencies characterized by selec-
tive predisposition to non-tuberculous mycobacteria (NTM) disease
include autosomal dominant and recessive disorders of the IL-
12/IL-23/IFN-γ axis including STAT1, and X-linked recessive defects
in NFκB-essential modulator (NEMO). In the process of evaluating
patients with disseminated NTM infections, we encountered a dis-
crete group of patients whose clinical course, laboratory features,
and family histories indicate a novel immunodeficiency.
Materials/Methods: We identified patients with severe NTM in-
fection, for whom mutations in the genes of the IL-12/IL-23/IFN-
gamma axis were excluded by function or sequence or both. We
also reviewed the medical charts of relevant family members.
Results: 14 patients were evaluated at the NIH and 9 affected fam-
ily members were identified (table). HIV was negative. This novel
syndrome is vertically transmitted, suggesting autosomal domi-
nance. The syndrome was identified by susceptibility to NTM in-
fections. It is characterized by profound circulating monocytope-
nia, and B and NK lymphocytopenia. HPV infection was common
(n=13) and severe with several cases of progression to neoplasia;
individual cases had severe EBV or VZV. Invasive fungal infections
occurred primarily with moulds (4 with Aspergillus spp. or its teleo-
morph, Neosartorya spp.), although 1 case involved C .neoformans
and 2 patients had disseminated histoplasmosis. Four patients de-
veloped pulmonary alveolar proteinosis (PAP), a disorder of exces-
sive lipoproteinaceous material within alveoli, but they did not
have mutations in the GM-CSF receptor or detectable autoantibod-
ies to GM-CSF. Nine cases progressed to myelodysplastic syndrome
or leukemia, 1 developed aplastic anemia, and 5 developed clonal
proliferation of large granular lymphocytes. Of the 23 cases, 11
(47.8%) are deceased.
Conclusions: This novel autosomal dominant immunodeficiency
syndrome is characterized by profound circulating monocytope-
nia and adult-onset mycobacterial disease. Infectious susceptibil-
ity extends to viruses, especially HPV, and to moulds. Development
of PAP, progression to myelodysplasia, and high mortality suggest
early definitive intervention such as bone marrow transplantation
is warranted.
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Idiopathic CD4+ Lymphocytopenia: Natural History and
Prognostic Factors.
Dimitrios Zonios, Judith Falloon, John Bennett, Pamela Shaw,
Doreen Chaitt, Michael Polis, Joseph Kovacs, Richard Davey, H.
Clifford Lane, Henry Masur, Irini Sereti. Laboratory of Clinical
Infectious Diseases and Laboratory of Immunoregulation, National
Institute of Allergy and Infectious Diseases, National Institutes of
Health, Bethesda, MD, USA
Background: Idiopathic CD4 lymphocytopenia (ICL) is a rare non-
HIV related syndrome first defined in 1992 as an absolute CD4 T
lymphocyte count of less than 300 cells/mm3 or of less than 20%
of total T cells on more than one occasion and the absence of any
defined immunodeficiency or therapy associated with low CD4 T
cells. It is a rare, heterogenous syndrome not caused by HIV-1 or 2,
HTLV-I or II or other transmissible agent.
Objectives: The clinical course, immunologic characteristics, CD4
T cell kinetics, long-term outcome and prognosis of this syndrome
have not been studied adequately.
Materials and Methods: Patients with ICL were enrolled between
1992 and 2006 in a NIH coordinated prospective natural history
clinical study. This included clinical assessment, history, immuno-
logic and virologic investigation while the patients were followed
at least annually.
Results: Thirty-nine patients (17 men, 22 women), 25 to 85 years
old with ICL were evaluated and thirty-six were followed for a
median of 49.5 months (range). Most of the patients presented
with cryptococcal and non-tuberculous mycobacterial infections,
while seven patients presented with no infection (incidental find-
ing of low CD4 T cell count). In thirty-two, CD4 T cell counts re-
mained below 300/mm3 during the entire study period without
progression of lymphopenia and in seven normalized after an av-
erage of 31 months. Using a linear mixed model approach to fit
the individual CD4 trajectories, the CD4 velocity was estimated at
0.66/mm3/month (95% CI: -0.20, 1.54) and was not significantly
different from zero (p=0.13). Overall, fifteen patients (41.6%) de-
veloped an opportunistic infection in follow up (mostly HPV, VZV in-
fections and candidiasis), five (13.8%) of which were AIDS defining
clinical conditions, and four patients (11.1%) developed autoim-
mune diseases. Patients without opportunistic infections (OIs) at
presentation remained asymptomatic. Seven patients died, four
from ICL related opportunistic infections within 42 months of di-
agnosis. CD8 T lymphocytopenia (<180/mm3) and high CD4 T cell
activation (measured by HLA-DR expression) at presentation were
associated with adverse outcome (ICL related death) (p=0.003 and
0.02 respectively).
Conclusions: ICL is a heterogeneous yet distinctive, clinically and
immunologically, from HIV infection condition. CD4 T cell counts
in ICL remain stable or improve in the majority of patients but
life-threatening OIs and autoimmune diseases can occur.
